T1	CHEM 79 88	sal común
#1	AnnotatorNotes T1	C0037494; sodium chloride; Inorganic Chemical
T2	PROC 107 115	prevenir
#2	AnnotatorNotes T2	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T3	DISO 119 129	nefropatía
#3	AnnotatorNotes T3	C0022658; Kidney Diseases; Disease or Syndrome
T4	CHEM 206 220	cloruro sódico
T5	PROC 246 256	profilaxis
#4	AnnotatorNotes T5	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T6	DISO 263 273	nefropatía
#5	AnnotatorNotes T6	C0022658; Kidney Diseases; Disease or Syndrome
T7	CHEM 287 303	contraste yodado
#6	AnnotatorNotes T7	C1960405; Iodinated contrast media; Indicator, Reagent, or Diagnostic Aid
T8	DISO 392 402	daño renal
#7	AnnotatorNotes T8	C1408258; Kidney damage; Finding
T9	DISO 521 545	nefropatía por contraste
#8	AnnotatorNotes T9	C4055183; Contrast - Induced Nephropathy; Disease or Syndrome
T10	PROC 628 631	TAC
#9	AnnotatorNotes T10	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T11	CHEM 536 545	contraste
#10	AnnotatorNotes T11	C0009924; Contrast Media; Indicator, Reagent, or Diagnostic Aid
T12	CHEM 636 645	contraste
#11	AnnotatorNotes T12	C0009924; Contrast Media; Indicator, Reagent, or Diagnostic Aid
T13	PROC 861 890	por escrito su consentimiento
#12	AnnotatorNotes T13	C0811746; Obtain written consent; Health Care Activity
T14	DISO 1067 1070	NIC
#13	AnnotatorNotes T14	C4055183; Contrast - Induced Nephropathy; Disease or Syndrome
T15	DISO 1072 1089	diabetes mellitus
#14	AnnotatorNotes T15	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T16	DISO 1091 1113	insuficiencia cardiaca
#15	AnnotatorNotes T16	C0018801; Heart failure; Disease or Syndrome
T17	PROC 1194 1208	fórmula MDRD-4
T18	DISO 1124 1143	insuficiencia renal
#16	AnnotatorNotes T18	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T19	PROC 1148 1176	filtrado glomerular estimado
#17	AnnotatorNotes T19	C3811844; Estimated Glomerular Filtration Rate; Laboratory Procedure
T20	PROC 1257 1276	Filtrado glomerular
#18	AnnotatorNotes T20	C0017654; Glomerular Filtration Rate; Diagnostic Procedure
T21	DISO 1314 1327	hipopotasemia
#19	AnnotatorNotes T21	C0020621; Hypokalemia; Finding
T22	CHEM 1329 1336	potasio
#20	AnnotatorNotes T22	C0032821; potassium; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T23	ANAT 1337 1343	sérico
#21	AnnotatorNotes T23	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T24	CHEM 1479 1491	nefrotóxicos
T25	CHEM 1493 1498	AINES
#22	AnnotatorNotes T25	C0003211; Anti-Inflammatory Agents, Non-Steroidal; Pharmacologic Substance
T26	CHEM 1500 1515	aminoglucósidos
#23	AnnotatorNotes T26	C0002556; Aminoglycosides; Organic Chemical · Pharmacologic Substance
T27	CHEM 1520 1535	quimioterápicos
#24	AnnotatorNotes T27	C0003392; Antineoplastic Agents; Organic Chemical · Pharmacologic Substance
T28	DISO 1673 1695	insuficiencia cardiaca
#25	AnnotatorNotes T28	C0018801; Heart failure; Disease or Syndrome
T29	DISO 1703 1721	EPOC descompensado
#26	AnnotatorNotes T29	C2887446; Decompensated COPD; Disease or Syndrome
T30	DISO 1724 1745	hipertensión arterial
#27	AnnotatorNotes T30	C0020538; Hypertensive disease; Disease or Syndrome
T31	DISO 1763 1776	Hipernatremia
#28	AnnotatorNotes T31	C0020488; Hypernatremia; Disease or Syndrome
T32	DISO 1779 1792	hipercloremia
#29	AnnotatorNotes T32	C0085679; Hyperchloremia; Disease or Syndrome
T33	PROC 61 75	administración
#30	AnnotatorNotes T33	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T34	CHEM 134 150	contraste iodado
T35	PROC 188 202	administración
#31	AnnotatorNotes T35	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T36	CHEM 444 453	contraste
#32	AnnotatorNotes T36	C0009924; Contrast Media; Indicator, Reagent, or Diagnostic Aid
T37	ANAT 397 402	renal
#33	AnnotatorNotes T37	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T38	PROC 421 439	prueba radiológica
T39	PROC 667 683	práctica clínica
T40	ANAT 1105 1113	cardiaca
#34	AnnotatorNotes T40	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T41	ANAT 1138 1143	renal
#35	AnnotatorNotes T41	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T42	PROC 1390 1404	procedimientos
#36	AnnotatorNotes T42	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T43	PROC 1329 1343	potasio sérico
#37	AnnotatorNotes T43	C0302353; Serum potassium measurement; Laboratory Procedure
T44	CHEM 1409 1418	contraste
#38	AnnotatorNotes T44	C0009924; Contrast Media; Indicator, Reagent, or Diagnostic Aid
T45	PROC 1461 1475	Administración
#39	AnnotatorNotes T45	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T46	DISO 1640 1671	Patología crónica descompensada
T47	ANAT 1687 1695	cardiaca
#40	AnnotatorNotes T47	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T48	ANAT 1737 1745	arterial
#41	AnnotatorNotes T48	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T49	ANAT 941 960	muestras biológicas
T50	Date 13 17	2013
T51	Route 93 101	vía oral
#42	AnnotatorNotes T51	C1527415; Oral Route of Drug administration; Functional Concept
T52	Route 221 225	oral
#43	AnnotatorNotes T52	C1527415; Oral Route of Drug administration; Functional Concept
T53	Route 228 239	intravenoso
#44	AnnotatorNotes T53	C1522726; Intravenous Route of Drug Administration; Functional Concept
T54	LIVB 307 327	pacientes ambulantes
#45	AnnotatorNotes T54	C0029921; Outpatients; Patient or Disabled Group
T55	LIVB 351 360	Pacientes
#46	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Spec_cue 370 379	riesgo de
T57	LIVB 480 489	Pacientes
#47	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Spec_cue 499 508	riesgo de
T59	LIVB 572 581	Pacientes
#48	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T63	Age 1003 1021	superior a 65 años
T64	Spec_cue 1057 1063	riesgo
T70	Route 1419 1430	intravenoso
#49	AnnotatorNotes T70	C1522726; Intravenous Route of Drug Administration; Functional Concept
T71	Duration 1434 1457	los quince días previos
T73	Duration 1568 1588	las últimas 72 horas
T75	Duration 1650 1657	crónica
#50	AnnotatorNotes T75	C0205191; chronic; Temporal Concept
T60	Duration 1619 1636	horas posteriores
T61	PHYS 1148 1167	filtrado glomerular
#51	AnnotatorNotes T61	C0232809; Glomerular filtration; Organ or Tissue Function; Laboratory Procedure
T62	ANAT 1157 1167	glomerular
#52	AnnotatorNotes T62	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
T65	ANAT 1266 1276	glomerular
#53	AnnotatorNotes T65	C0022663; Kidney Glomerulus; Body Part, Organ, or Organ Component | C1284485; Entire glomerulus; Body Part, Organ, or Organ Component
T66	PROC 731 737	diseño
#54	AnnotatorNotes T66	C0035171; Research Design; Research Activity (?)
A1	Assertion T8 Speculated
A2	Assertion T9 Speculated
A3	Assertion T14 Speculated
A4	Status T42 History_of
A5	Status T44 History_of
A6	Status T45 History_of
A7	Status T24 History_of
A8	Status T25 History_of
A9	Status T26 History_of
A10	Status T27 History_of
#55	AnnotatorNotes T34	C1960405; Iodinated contrast media; Indicator, Reagent, or Diagnostic Aid
#56	AnnotatorNotes T4	C0037494; sodium chloride; Inorganic Chemical
#57	AnnotatorNotes T38	C1306645; Plain x-ray; Diagnostic Procedure | C1962945; Radiographic imaging procedure; Diagnostic Procedure
#58	AnnotatorNotes T49	C2347026; Biospecimen; Body Substance
T67	Quantifier_or_Qualifier 1551 1563	nefrotóxicos
A11	Assertion T67 Speculated
#59	AnnotatorNotes T67	C1514118; Nephrotoxic; Qualitative Concept
T68	Spec_cue 1536 1550	potencialmente
T69	Spec_cue 766 774	posibles
T72	Observation 775 782	riesgos
A12	Assertion T72 Speculated
R1	Speculation Arg1:T69 Arg2:T72
T74	Neg_cue 813 826	denegación de
T76	CONC 827 836	continuar
A13	Assertion T76 Negated
R2	Negation Arg1:T74 Arg2:T76
R3	Used_for Arg1:T1 Arg2:T33
R4	Has_Route_or_Mode Arg1:T1 Arg2:T51
R5	Used_for Arg1:T1 Arg2:T2
R6	Before Arg1:T2 Arg2:T3
R7	Causes Arg1:T34 Arg2:T3
R8	Causes Arg1:T7 Arg2:T6
R9	Experiences Arg1:T54 Arg2:T35
R10	Experiences Arg1:T54 Arg2:T5
R12	Used_for Arg1:T4 Arg2:T35
R13	Has_Route_or_Mode Arg1:T4 Arg2:T52
R14	Has_Route_or_Mode Arg1:T4 Arg2:T53
R15	Before Arg1:T5 Arg2:T6
R11	Experiences Arg1:T54 Arg2:T7
R16	Speculation Arg1:T56 Arg2:T8
R17	Location_of Arg1:T37 Arg2:T8
R18	Experiences Arg1:T55 Arg2:T38
R19	Before Arg1:T36 Arg2:T8
R20	Used_for Arg1:T36 Arg2:T38
R21	Before Arg1:T38 Arg2:T8
T77	Observation 365 379	alto riesgo de
#60	AnnotatorNotes T77	C0332167; High risk of; Finding
T78	Observation 494 508	alto riesgo de
#61	AnnotatorNotes T78	C0332167; High risk of; Finding
R22	Before Arg1:T77 Arg2:T8
R23	Experiences Arg1:T55 Arg2:T77
R24	Experiences Arg1:T57 Arg2:T78
R25	Before Arg1:T78 Arg2:T9
R26	Causes Arg1:T11 Arg2:T9
R27	Speculation Arg1:T58 Arg2:T9
R28	Experiences Arg1:T59 Arg2:T10
R29	Used_for Arg1:T12 Arg2:T10
T79	Observation 702 721	recibir información
#62	AnnotatorNotes T79	C0587903; Patient information status; Finding (?)
R31	Before Arg1:T79 Arg2:T13
R32	Before Arg1:T79 Arg2:T72
R33	Before Arg1:T79 Arg2:T76
T80	Observation 896 920	participar en el estudio
#63	AnnotatorNotes T80	C1278516; Patient participation status; Finding
R34	Before Arg1:T13 Arg2:T80
R36	Speculation Arg1:T64 Arg2:T14
T81	Observation 1045 1063	factores de riesgo
#64	AnnotatorNotes T81	C0035648; risk factors; Finding
R37	Before Arg1:T81 Arg2:T14
R38	Before Arg1:T15 Arg2:T14
R39	Before Arg1:T16 Arg2:T14
R40	Before Arg1:T18 Arg2:T14
R41	Location_of Arg1:T40 Arg2:T16
R42	Location_of Arg1:T62 Arg2:T61
R43	Location_of Arg1:T62 Arg2:T19
T82	Result_or_Value 1209 1229	entre 30 y 60 ml/min
#65	AnnotatorNotes T17	C1980036; Creatinine-based formula (MDRD); Laboratory Procedure
R46	Location_of Arg1:T65 Arg2:T20
T83	Result_or_Value 1277 1297	inferior a 30 ml/min
R47	Has_Result_or_Value Arg1:T20 Arg2:T83
R49	Location_of Arg1:T23 Arg2:T43
T84	Result_or_Value 1344 1364	inferior a 3,5 mEq/L
R50	Has_Result_or_Value Arg1:T43 Arg2:T84
R51	Has_Result_or_Value Arg1:T19 Arg2:T82
R52	Used_for Arg1:T44 Arg2:T42
R53	Overlap Arg1:T42 Arg2:T71
R54	Has_Route_or_Mode Arg1:T44 Arg2:T70
R55	Used_for Arg1:T24 Arg2:T45
R56	Used_for Arg1:T25 Arg2:T45
R57	Used_for Arg1:T26 Arg2:T45
R58	Used_for Arg1:T27 Arg2:T45
R59	Speculation Arg1:T68 Arg2:T67
R60	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T67
R61	Overlap Arg1:T24 Arg2:T73
R62	Overlap Arg1:T25 Arg2:T73
R63	Overlap Arg1:T26 Arg2:T73
R64	Overlap Arg1:T27 Arg2:T73
T85	CONC 1592 1601	previsión
#66	AnnotatorNotes T85	C1301732; Planned; Functional Concept
R65	After Arg1:T24 Arg2:T60
R66	After Arg1:T25 Arg2:T60
R67	After Arg1:T26 Arg2:T60
R68	After Arg1:T27 Arg2:T60
R69	Location_of Arg1:T47 Arg2:T28
R74	Has_Duration_or_Interval Arg1:T46 Arg2:T75
R75	Location_of Arg1:T48 Arg2:T30
T86	Quantifier_or_Qualifier 1696 1701	aguda
#67	AnnotatorNotes T86	C0439557; Acute phase; Temporal Concept
R76	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T86
T87	Quantifier_or_Qualifier 1746 1760	mal controlada
#68	AnnotatorNotes T87	C3853134; Poorly controlled; Functional Concept
R77	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T87
R80	Experiences Arg1:T57 Arg2:T9
R81	Experiences Arg1:T55 Arg2:T8
#69	AnnotatorNotes T72	C0559571; At risk; Finding
R82	Used_for Arg1:T4 Arg2:T5
#70	AnnotatorNotes T76	C0549178; Continuous; Idea or Concept (?)
R44	Experiences Arg1:T54 Arg2:T6
R30	Experiences Arg1:T59 Arg2:T72
T88	Quantifier_or_Qualifier 1114 1121	estable
#71	AnnotatorNotes T88	C0205360; Stable status; Qualitative Concept
R35	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T88
A14	Experiencer T54 Patient
A15	Experiencer T55 Patient
A16	Experiencer T57 Patient
A17	Experiencer T59 Patient
A18	Status T10 Future
A19	Status T12 Future
A20	Status T45 Future
A21	Status T24 Future
A22	Status T25 Future
A23	Status T26 Future
A24	Status T27 Future
